ECJ: potential competition exists between originators and generics
The European Court of Justice has held that competition can exist between a pharmaceutical patent-holder and generic drugmakers that are in a patent dispute.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.